4
CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective: to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel disease Study: multicenter, randomised trial Population: patients with Lmain/3 VD amerable to equivalent revascularization using either PES or CABG Endpoint: MACCE: death, stroke, MI and repeat revascularization

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective:to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel

Embed Size (px)

Citation preview

Page 1: CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective:to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year

Objective: to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel diseaseStudy: multicenter, randomised trialPopulation: patients with Lmain/3 VD amerable to equivalent revascularization using either PES or CABGEndpoint: MACCE: death, stroke, MI and repeat revascularization

Page 2: CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective:to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year

Page 3: CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective:to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year

Page 4: CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year Objective:to compare the outcomes of CABG with paclitaxel stent for the treatment of Lmain/3 vessel

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year

Conclusion

MACCE was significantly higher at 3 years with PCI compared to CABG for treatment of LM/ 3 VDisease

Kappetein EHJ 2011;32:2125-34